ES2061609T3 - 2',3'-dideoxi-2'-fluoro-nucleosidos. - Google Patents

2',3'-dideoxi-2'-fluoro-nucleosidos.

Info

Publication number
ES2061609T3
ES2061609T3 ES88118870T ES88118870T ES2061609T3 ES 2061609 T3 ES2061609 T3 ES 2061609T3 ES 88118870 T ES88118870 T ES 88118870T ES 88118870 T ES88118870 T ES 88118870T ES 2061609 T3 ES2061609 T3 ES 2061609T3
Authority
ES
Spain
Prior art keywords
dideoxi
nucleosides
fluoro
fluoronucleosides
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118870T
Other languages
English (en)
Inventor
Roman Z Sterzycki
Muzammil M Mansuri
John C Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2061609T3 publication Critical patent/ES2061609T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS 2'',3''- DIDESOXI FLUORONUCLEOSIDOS Y 2'',3''- DIDESOXI - 2'',3''- DIDESHIDRO 2''-FLUORONUCLEOSIDOS Y A PROCEDIMIENTOS PARA SU PREPARACION. LOS COMPUESTOS ASI PRODUCIDOS MUESTRAN EFECTOS ANTIVIRICOS Y MAS PARTICULARMENTE ANTI - HIV (VIRUS DE INMUNODEFICIENCIA HUMANA), TERAPEUTICAMENTE UTILES.
ES88118870T 1987-11-12 1988-11-11 2',3'-dideoxi-2'-fluoro-nucleosidos. Expired - Lifetime ES2061609T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/120,051 US4908440A (en) 1987-11-12 1987-11-12 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Publications (1)

Publication Number Publication Date
ES2061609T3 true ES2061609T3 (es) 1994-12-16

Family

ID=22387985

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118870T Expired - Lifetime ES2061609T3 (es) 1987-11-12 1988-11-11 2',3'-dideoxi-2'-fluoro-nucleosidos.

Country Status (22)

Country Link
US (4) US4908440A (es)
EP (1) EP0316017B1 (es)
JP (4) JPH01153698A (es)
KR (1) KR920004459B1 (es)
AT (1) ATE100461T1 (es)
AU (1) AU615960B2 (es)
CA (1) CA1340961C (es)
CZ (3) CZ278394B6 (es)
DD (1) DD275874A5 (es)
DE (1) DE3887273T2 (es)
DK (1) DK173971B1 (es)
ES (1) ES2061609T3 (es)
FI (1) FI90244C (es)
HU (1) HU199499B (es)
IE (1) IE62227B1 (es)
IL (1) IL88330A (es)
NO (1) NO169492C (es)
NZ (1) NZ226845A (es)
PT (1) PT88994B (es)
SK (2) SK278017B6 (es)
YU (1) YU47121B (es)
ZA (1) ZA888313B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
US5198539A (en) * 1988-08-19 1993-03-30 Burroughs Wellcome Co. 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
GR1000618B (el) * 1989-03-17 1992-08-31 Oncogen Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.
FI95384C (fi) * 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
JP3207852B2 (ja) * 1989-09-15 2001-09-10 サザン リサーチ インスティテュート 抗ウィルス剤及び抗癌剤としての２′―デオキシ―４′―チオリボヌクレオシド
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
AU1254892A (en) * 1990-12-18 1992-07-22 Sloan-Kettering Institute For Cancer Research Novel synthesis of 2'-"up" fluorinated 2''-deoxy-arabinofuranosylpurines
US5712477A (en) * 1996-05-14 1998-01-27 Allen-Bradley Company, Inc. System to provide alignment and troubleshooting aid photoelectric sensors through alternating numeric display
CN101089010B (zh) * 1998-02-25 2011-12-14 埃莫里大学 2＇-氟代核苷
KR100954390B1 (ko) 1998-02-25 2010-04-26 에모리 유니버시티 2'-플루오로뉴클레오사이드
PT1411954E (pt) 2000-10-18 2011-03-16 Pharmasset Inc Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
US6949522B2 (en) 2001-06-22 2005-09-27 Pharmasset, Inc. β-2′- or 3′-halonucleosides
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US8895531B2 (en) 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
US20070243798A1 (en) * 2006-04-18 2007-10-18 3M Innovative Properties Company Embossed structured abrasive article and method of making and using the same
KR20160076373A (ko) 2014-12-22 2016-06-30 김기범 양식용 패각 고정을 위한 로프 어셈블리

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE292023C (es) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
JPH01100190A (ja) * 1987-10-12 1989-04-18 Asahi Glass Co Ltd ヌクレオシド類
EP0314011A3 (de) * 1987-10-30 1990-04-11 F. Hoffmann-La Roche Ag Purinderivate

Also Published As

Publication number Publication date
EP0316017A3 (en) 1990-05-30
EP0316017B1 (en) 1994-01-19
HUT48266A (en) 1989-05-29
AU2504288A (en) 1989-05-25
DE3887273D1 (de) 1994-03-03
US4908440A (en) 1990-03-13
SK277919B6 (en) 1995-08-09
JP2811561B2 (ja) 1998-10-15
FI885153A0 (fi) 1988-11-09
KR920004459B1 (ko) 1992-06-05
JPH0648947A (ja) 1994-02-22
EP0316017A2 (en) 1989-05-17
CZ278366B6 (en) 1993-12-15
CZ545190A3 (en) 1993-08-11
NZ226845A (en) 1991-10-25
IL88330A (en) 1995-03-15
CZ743188A3 (en) 1993-08-11
ZA888313B (en) 1989-07-26
AU615960B2 (en) 1991-10-17
JPH0649091A (ja) 1994-02-22
FI90244C (fi) 1994-01-10
DE3887273T2 (de) 1994-05-19
FI885153A (fi) 1989-05-13
YU47121B (sh) 1994-12-28
KR890008161A (ko) 1989-07-10
DK631688A (da) 1989-05-13
JP2699049B2 (ja) 1998-01-19
NO169492B (no) 1992-03-23
CZ278395B6 (en) 1993-12-15
SK743188A3 (en) 1995-08-09
US5126506A (en) 1992-06-30
IE883406L (en) 1989-05-12
SK545290A3 (en) 1995-10-11
PT88994A (pt) 1989-09-14
DK631688D0 (da) 1988-11-11
IE62227B1 (en) 1995-01-11
FI90244B (fi) 1993-09-30
JP2699050B2 (ja) 1998-01-19
SK278017B6 (en) 1995-10-11
DK173971B1 (da) 2002-03-18
IL88330A0 (en) 1989-06-30
HU199499B (en) 1990-02-28
CZ278394B6 (en) 1993-12-15
JPH09183731A (ja) 1997-07-15
YU204888A (en) 1990-04-30
NO884995D0 (no) 1988-11-09
CZ545290A3 (en) 1993-08-11
ATE100461T1 (de) 1994-02-15
DD275874A5 (de) 1990-02-07
PT88994B (pt) 1995-03-31
NO169492C (no) 1993-01-12
JPH01153698A (ja) 1989-06-15
US4973677A (en) 1990-11-27
US5218106A (en) 1993-06-08
CA1340961C (en) 2000-04-18
NO884995L (no) 1989-05-16

Similar Documents

Publication Publication Date Title
ES2061609T3 (es) 2',3'-dideoxi-2'-fluoro-nucleosidos.
DE3872495T2 (de) Herstellung von 3,3,3-trifluoropropen.
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
FI88303B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2,3-disubstituerade isoxazolidiner
DE3888530D1 (de) 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate.
OA06289A (fr) La préparation d'agents antiviraux.
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
ATA320788A (de) 5,5-dimethyl-3-phenylvinyl-1-aminoalkoxy-iminocyclohex-2-enderivate
FI883266A (fi) 4-aminosubstituerade 1,2-dihydronaftalenderivat.
FI883088A (fi) Nya 3',4'-dikvaevesubstituerade epipodofyllotoxinglukosidderivat.
IT8323545A0 (it) Composizioni terapeutiche adattivita' antivirale.
FI881899A (fi) Nya 2 ,16 -diaminoandrostaner.
FI882210A0 (fi) Enskilda isomerer av endo-bicyklo (2.2.1) heptyladenosin.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO880127D0 (no) Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
TR23947A (tr) Suebstituee edilmis 2,6-suebsituetuee piridin bilesik- leri
NO911970L (no) Mellomprodukter for fremstilling av antivirale tetrahydroimidazo(1,4)benzodiazepin-2-oner.
IT8741520A0 (it) 2-osso-4-(2'-difluorometiltiofenil)-5-metassicarbonil-6-metil-1,2,3,4tetraidropirimidina.
LT2342B (lt) 2,6-dioksopiperazino gavimo budas
MX9203634A (es) Derivados de pirocatecol 3,5-disubstituidos.
LV5470A3 (lv) 3-(2,2-Difluorbenzodioksol-4-il)-4-cianpirola iegusanas panemiens

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316017

Country of ref document: ES